IRCCS Istituto Ortopedico Rizzoli di Bologna - Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Bordeaux - Institut Bergonié, GlaxoSmithKline, University of Texas at Houston - MD Anderson Cancer Center, University College London - University College London Hospitals NHS Foundation Trust, Fondazione IRCCS Istituto Nazionale dei Tumori, Royal Marsden NHS Foundation Trust, Harvard University - Dana-Farber Cancer Institute, Universidad Autónoma de Madrid - FIIS-Fundacion Jimenez Diaz University Hospital, University of Seville - Institute of Biomedicine of Seville, General Hospital, Prato, Candiolo Cancer Institute, IRCCS Regina Elena National Cancer Institute, Istituto Oncologico Veneto – IRCCS, Yeshiva University - Montefiore Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology, Universidad Autónoma de Madrid - FIIS-Fundacion Jimenez Diaz University Hospital, University of Lausanne - Lausanne University Hospital, Kantonsspital St Gallen, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Seville - Institute of Biomedicine of Seville, IRCCS Istituto Ortopedico Rizzoli di Bologna, University Hospital General de Villalba, Harvard University - Dana-Farber Cancer Institute, University Campus Bio-Medico, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Padua - Department of Medicine, IRCCS Istituto Ortopedico Rizzoli di Bologna, IRCCS Istituto Ortopedico Rizzoli di Bologna, University of Padua - Department of Medicine, IRCCS Istituto Ortopedico Rizzoli di Bologna, Fondazione IRCCS Istituto Nazionale dei Tumori - Department of Medical Oncology and University Campus Bio-Medico